Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;62(1):69-74.
doi: 10.1093/tropej/fmv063. Epub 2015 Sep 30.

Use of Nasal Bubble CPAP in Children with Hypoxemic Clinical Pneumonia-Report from a Resource Limited Set-Up

Affiliations

Use of Nasal Bubble CPAP in Children with Hypoxemic Clinical Pneumonia-Report from a Resource Limited Set-Up

Muralidharan Jayashree et al. J Trop Pediatr. 2016 Feb.

Abstract

Objective: Nasal bubble continuous positive airway pressure (bCPAP) is preferred in developing economies for easy applicability and low cost. Because its use in older children is unexplored, we sought to evaluate its utility in hypoxemic clinical pneumonia.

Methods: Of 330 children (1 month-12 years) with clinical pneumonia enrolled prospectively over 1 year, those with increased work of breathing and/or SpO2 <92% received bCPAP delivered via an underwater 'T' tube through nasal prongs. Proportion requiring intubation despite bCPAP constituted primary outcome. Incidence of complications, duration of bCPAP and emergency stay were secondary outcomes.

Results: Oxygen was initiated by nasal prongs (NPO2) in 204 (61.8%), and by bCPAP in 110 (33.3%). Sixteen (4.8%) were intubated at the outset. Fifty-three (25.9%) on NPO2 were shifted to bCPAP for worsening distress and hypoxemia. Only three (1.8%) from bCPAP group required intubation, of which one died. Failure rate and complications were negligent. The median emergency stay was 4 days.

Conclusions: Nasal bCPAP was safe and effective in children with hypoxemic clinical pneumonia.

Keywords: clinical pneumonia; nasal bubble CPAP; respiratory distress Children.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
bCPAP circuit.

References

    1. Verder H, Robertson B, Greisens G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med 1994;331:1051–5. - PubMed
    1. Larrar S, Essouri S, Durand P, et al. Effects of nasal continuous positive airway pressure ventilation in infants with severe acute bronchiolitis. Arch Pediatr 2006;13:1397–403. - PubMed
    1. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26–30. - PubMed
    1. Gittermann MK, Fusch C, Gittermann AR, et al. Early nasal continuous positive airway pressure treatment reduces need for intubation in very low birth infants. Eur J Pediatr 1997;156:384–8. - PubMed
    1. Lipsten E, Aghai ZH, Pyon KH, et al. Work of breathing during nasal continuous positive airway pressure in preterm infants: a comparison of bubble vs variable flow devices. J Perinatol 2005;25:453–8. - PubMed